Type your tag names separated by a space and hit enter

Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease

Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease ID - 1305017 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305017/all/Long_acting_beta2_agonist_in_addition_to_tiotropium_versus_either_agent_alone_for_chronic_obstructive_pulmonary_disease PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -